Plain-English translation of NCT05106725 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The Healthiomics study is collecting health information, medical records, and data from wearable devices to better understand brain tumors and neurological disorders. Researchers want to find patterns—called biomarkers—that can predict which patients will benefit most from specific treatments. This could help doctors personalize care and make better treatment decisions for future patients.
Even with advanced surgery and chemotherapy, brain tumors and related neurological conditions remain difficult to treat, and doctors currently have limited ways to predict which patients will respond well to which treatments. This study aims to discover biological markers that could help doctors choose the right treatment for each patient before starting therapy.
You likely qualify if…
You likely don't qualify if…
You would allow the study team to collect your health information, medical records, and data from any wearable devices you use (like fitness trackers). You may also be asked about your symptoms and how your condition affects your daily life. The study will compare information from people with brain tumors and neurological disorders to information from healthy volunteers to identify patterns that help predict treatment outcomes.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States
Sponsor
CureScience
Enrollment target
~3,500 participants
Started
October 2021
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amanda Wilburn
CureScience
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.